Results 281 to 290 of about 98,296 (378)
Nonsymmetric α‐hydroxy‐ethylidenebisphosphonates (HEBPs) are synthesized by the Pudovik reaction of dialkyl α‐oxo‐ethylphosphonates and P‐reagents (such as dialkyl phosphites, alkyl phenyl‐H‐phosphinates or diarylphosphine oxides). In the presence of 40% diethylamine, the primary adducts rearrange to the corresponding phosphonoyl‐phosphonate and ...
Zsuzsanna Szalai +8 more
wiley +1 more source
Efficacy and safety of bisphosphonates in pediatric glucocorticoid-induced osteoporosis: a meta-analysis and pharmacovigilance study. [PDF]
Xu X +7 more
europepmc +1 more source
Diagnosis of B-cell lymphoproliferative disorder through concomitant management of medication-related osteonecrosis of the jaw: A case report [PDF]
Buckley, James G. +3 more
core +1 more source
Risk of atypical femoral fracture during and after bisphosphonate use.
J. Schilcher +3 more
semanticscholar +1 more source
Twenty Years of Continuous Bisphosphonate Use Leading to Atypical Bilateral Femoral Fractures: A Case Report. [PDF]
Monachino AM +4 more
europepmc +1 more source
J. Hagen +9 more
semanticscholar +1 more source
Aims To develop an evidence‐ and consensus‐based patient prioritization tool for use by UK mental health inpatient pharmacy teams. Methods A modified‐Delphi technique was used to obtain experts' agreement on the content, design and practical use of the patient prioritization tool.
Fatima Q. Alshaikhmubarak +3 more
wiley +1 more source
Bisphosphonate-Induced Atypical Femoral Fractures in Pediatric Patients With Lipoprotein Receptor-Related Protein 5 (LRP5) Gene Mutation: A Case Report of Twin Patients. [PDF]
Sarhan M, Aly M, Williams P, Humphry S.
europepmc +1 more source
Post‐COVID‐19 Maxillary Bony Sequestration: A Case Report on Mucormycosis Challenges
ABSTRACT COVID‐19‐associated mucormycosis (CAM) is a severe opportunistic infection, typically affecting immunocompromised patients. Maxillary bony sequestration as a delayed complication in immunocompetent individuals is rare, highlighting diagnostic and therapeutic challenges.
Saleh Mohebbi +3 more
wiley +1 more source

